Camille Vaganay
Paris, 75010, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Splicing-associated network PAK1-CLK1/4-SRRM1 is a vulnerability to overcome chemoresistance in human and mouse acute myeloid leukemia.
Journal: Science translational medicine
Published: July 08, 2026
Reprogramming RIPK3-induced cell death in malignant B cells promotes immune-mediated tumor control.
Journal: Science advances
Published: August 15, 2025
Screening of ETO2-GLIS2-induced Super Enhancers identifies targetable cooperative dependencies in acute megakaryoblastic leukemia.
Journal: Science advances
Published: February 09, 2022
A multiparametric niche-like drug screening platform in acute myeloid leukemia.
Journal: Blood cancer journal
Published: November 30, 2021
Cystine uptake inhibition potentiates front-line therapies in acute myeloid leukemia.
Journal: Leukemia
Published: October 12, 2021
Endothelial cells: major players in acute myeloid leukaemia.
Journal: Blood reviews
Published: September 13, 2021
Tumor Lysis Syndrome and AKI: Beyond Crystal Mechanisms.
Journal: Journal of the American Society of Nephrology : JASN
Published: July 27, 2021
Targeting acute myeloid leukemia dependency on VCP-mediated DNA repair through a selective second-generation small-molecule inhibitor.
Journal: Science translational medicine
Published: December 12, 2020
The Folate Cycle Enzyme MTHFR Is a Critical Regulator of Cell Response to MYC-Targeting Therapies.
Journal: Cancer discovery
Published: August 18, 2019
Showing 1-10 of 10
Last Updated: 09/26/2026